Bank of New York Mellon
HITK

Bank of New York Mellon’s HI-TECH PHARMACAL INC HITK Stock Holding History

Bank of New York Mellon’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-123,688
Closed -$5.36M – 4332
2014
Q1 		$5.36M Sell
123,688
-2,291
-2% -$99.3K ﹤0.01% 2280
2013
Q4 		$5.47M Buy
125,979
+2,723
+2% +$118K ﹤0.01% 2245
2013
Q3 		$5.32M Buy
123,256
+5,311
+5% +$203K ﹤0.01% 2207
2013
Q2 		$3.92M Buy
+117,945
New +$3.93M ﹤0.01% 2342

Bank of New York Mellon's HITK Position: Q2 2014 in Review

Bank of New York Mellon sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 123,688 shares — an estimated $5.36M sold.

Bank of New York Mellon first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $5.47M in Q4 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Bank of New York Mellon reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 123,688 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $5.36M.
  • Bank of New York Mellon first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • Bank of New York Mellon's HI-TECH PHARMACAL INC position peaked at $5.47M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Bank of New York Mellon's 13F filing for Q2 2014, filed 12 Aug 2014.